Severe Injection Site Reaction to Insulin Detemir-Reference-Cited by-同舟云学术

Severe Injection Site Reaction to Insulin Detemir

Published:2006-04-01 Issue:4 Volume:29 Page:946-946
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Blumer Ian R.¹

Affiliation:

1. From the Charles H. Best Diabetes Centre, Ajax, Ontario, Canada

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/29/4/946/650510/946.pdf

Reference2 articles.

1. European Medicines Agency: Levemir European Public Assessment Report, Levemir-H-528-II-01 [article online], 2003. Available at http://www.emea.eu.int/humandocs/Humans/EPAR/levemir/levemir.htm. Accessed 19 December 2005

2. Darmon P, Castera V, Koeppel M, Petitjean C, Dutour A: Type III allergy to insulin detemir (Letter). Diabetes Care 28:2980, 2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study;Diabetologia;2022-05-04

2. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs;The Journal of Allergy and Clinical Immunology: In Practice;2020-10

3. Die Hyposensibilisierung bleibt nur selten als Therapieoption übrig;hautnah dermatologie;2015-01-28

4. Die Hyposensibilisierung bleibt nur selten als Therapieoption übrig;Info Diabetologie;2014-08-27

5. Cutaneous allergy to insulin: Could statins and ACE inhibitors play a role? A case report;Diabetes Research and Clinical Practice;2014-04